CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional paid-in capital	Additional paid-in capital Cumulative Effect, Period of Adoption, Adjustment	Retained earnings (accumulated deficit)	Retained earnings (accumulated deficit) Cumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive (loss)
Balance, beginning of period (in shares) at Dec. 31, 2020			80,890
Balance, beginning of period at Dec. 31, 2020	$ 542,172	$ (52,205)	$ 809	$ 204,432	$ (61,604)	$ 339,879	$ 9,399	$ (2,948)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)			(432)
Repurchase of common stock	(53,610)		$ (5)	(53,605)
Issuance of common stock for stock compensation plans (in shares)			1,153
Issuance of common stock for stock compensation plans	(69,925)		$ 12	(69,937)
Issuance of common stock under the employee stock purchase plan (in shares)			101
Issuance of common stock under the employee stock purchase plan	10,554		$ 1	10,553
Stock-based compensation	115,971			115,971
Cash dividends declared	(9,789)					(9,789)
Other Comprehensive income (loss)	(4,040)							(4,040)
Net income (loss)	(63,040)					(63,040)
Balance, end of period (in shares) at Dec. 31, 2021			81,712
Balance, end of period at Dec. 31, 2021	416,088		$ 817	145,810		276,449		(6,988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)			(280)
Repurchase of common stock	(24,508)		$ (2)	(24,506)
Issuance of common stock for stock compensation plans (in shares)			754
Issuance of common stock for stock compensation plans	(20,620)		$ 7	(20,627)
Issuance of common stock under the employee stock purchase plan (in shares)			250
Issuance of common stock under the employee stock purchase plan	9,172		$ 2	9,170
Stock-based compensation	122,229			122,229
Cash dividends declared	(9,854)			(2,474)		(7,380)
Other Comprehensive income (loss)	(16,082)							(16,082)
Net income (loss)	$ (345,582)					(345,582)
Balance, end of period (in shares) at Dec. 31, 2022	82,436		82,436
Balance, end of period at Dec. 31, 2022	$ 130,843		$ 824	229,602		(76,513)		(23,070)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for stock compensation plans (in shares)			1,212
Issuance of common stock for stock compensation plans	8,905		$ 12	8,893
Issuance of common stock under the employee stock purchase plan (in shares)			192
Issuance of common stock under the employee stock purchase plan	7,744		$ 2	7,742
Stock-based compensation	143,352			143,352
Cash dividends declared	(10,005)			(10,005)
Other Comprehensive income (loss)	5,191							5,191
Net income (loss)	$ 67,808					67,808
Balance, end of period (in shares) at Dec. 31, 2023	83,840		83,840
Balance, end of period at Dec. 31, 2023	$ 353,838		$ 838	$ 379,584		$ (8,705)		$ (17,879)